Sarah James
Stock Analyst at Cantor Fitzgerald
(1.82)
# 3,059
Out of 4,734 analysts
269
Total ratings
26.09%
Success rate
-6.73%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Reiterates: Overweight | $700 | $524.99 | +33.34% | 17 | Jan 17, 2025 | |
| CNC Centene | Reiterates: Overweight | $90 | $63.66 | +41.38% | 12 | Dec 11, 2024 | |
| ACHC Acadia Healthcare Company | Reiterates: Neutral | $52 | $44.37 | +17.20% | 13 | Dec 10, 2024 | |
| PGNY Progyny | Maintains: Overweight | $30 → $17 | $21.48 | -20.86% | 14 | Nov 14, 2024 | |
| THC Tenet Healthcare | Maintains: Overweight | $168 → $177 | $134.43 | +31.67% | 19 | Oct 30, 2024 | |
| UHS Universal Health Services | Reiterates: Neutral | $219 | $188.78 | +16.01% | 24 | Oct 25, 2024 | |
| MOH Molina Healthcare | Reiterates: Overweight | $406 | $297.44 | +36.50% | 11 | Oct 24, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $400 | $288.59 | +38.60% | 19 | Oct 23, 2024 | |
| ELV Elevance Health | Maintains: Overweight | $600 → $485 | $389.22 | +24.61% | 18 | Oct 18, 2024 | |
| TBRG TruBridge | Reiterates: Overweight | $13 | $23.34 | -44.30% | 5 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $43 | $20.47 | +110.06% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $5.68 | +181.69% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $392 | $318.47 | +23.09% | 18 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $395 | $284.67 | +38.76% | 19 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $62 | $53.15 | +16.65% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $5.17 | +190.14% | 10 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $4.31 | +16.01% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $9.50 | +5.26% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $92.18 | +9.57% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $169.97 | -21.75% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $17.89 | +134.77% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $3.70 | +35.14% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $4.95 | +1.01% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $14.57 | +44.13% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $60.19 | -35.21% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $74.19 | +160.14% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.30 | - | 2 | Mar 1, 2017 |
UnitedHealth Group
Jan 17, 2025
Reiterates: Overweight
Price Target: $700
Current: $524.99
Upside: +33.34%
Centene
Dec 11, 2024
Reiterates: Overweight
Price Target: $90
Current: $63.66
Upside: +41.38%
Acadia Healthcare Company
Dec 10, 2024
Reiterates: Neutral
Price Target: $52
Current: $44.37
Upside: +17.20%
Progyny
Nov 14, 2024
Maintains: Overweight
Price Target: $30 → $17
Current: $21.48
Upside: -20.86%
Tenet Healthcare
Oct 30, 2024
Maintains: Overweight
Price Target: $168 → $177
Current: $134.43
Upside: +31.67%
Universal Health Services
Oct 25, 2024
Reiterates: Neutral
Price Target: $219
Current: $188.78
Upside: +16.01%
Molina Healthcare
Oct 24, 2024
Reiterates: Overweight
Price Target: $406
Current: $297.44
Upside: +36.50%
The Cigna Group
Oct 23, 2024
Reiterates: Overweight
Price Target: $400
Current: $288.59
Upside: +38.60%
Elevance Health
Oct 18, 2024
Maintains: Overweight
Price Target: $600 → $485
Current: $389.22
Upside: +24.61%
TruBridge
Oct 4, 2024
Reiterates: Overweight
Price Target: $13
Current: $23.34
Upside: -44.30%
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $20.47
Upside: +110.06%
Oct 4, 2024
Reiterates: Overweight
Price Target: $16
Current: $5.68
Upside: +181.69%
Oct 4, 2024
Reiterates: Overweight
Price Target: $392
Current: $318.47
Upside: +23.09%
Oct 1, 2024
Reiterates: Neutral
Price Target: $395
Current: $284.67
Upside: +38.76%
Oct 1, 2024
Reiterates: Neutral
Price Target: $62
Current: $53.15
Upside: +16.65%
Sep 20, 2024
Reiterates: Overweight
Price Target: $15
Current: $5.17
Upside: +190.14%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $4.31
Upside: +16.01%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $9.50
Upside: +5.26%
Jul 25, 2024
Reiterates: Neutral
Price Target: $101
Current: $92.18
Upside: +9.57%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $169.97
Upside: -21.75%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $17.89
Upside: +134.77%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $3.70
Upside: +35.14%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $4.95
Upside: +1.01%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $14.57
Upside: +44.13%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $60.19
Upside: -35.21%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $74.19
Upside: +160.14%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.30
Upside: -